Incidence and prevalence of drug-resistant epilepsy: a systematic review and meta-analysis
The guidance above is based on clinical principles only
Various GLP-1 agonists, including NLY01, liraglutide, semaglutide, dulaglutide, and Exendin-4, were investigated
Concussion participants were randomized to either the 3- or 6 month follow-up sessions, this creates a discontinuity of each participant which may affect our ability to observe longitudinal metabolite changes or specific individual differences
From just 200 procedures in 2004, the number soared to 40,000 in 2022 - a 200-fold rise
One small case study published last year found that six people who screened positive for alcohol use disorder saw a clinically significant decrease in symptoms while using semaglutide, the active ingredient in Ozempic and another medication, Wegovy, for weight loss